Literature DB >> 23093472

Ocular myositis.

Clare L Fraser1, Simon E Skalicky, Avinash Gurbaxani, Peter McCluskey.   

Abstract

Ocular myositis frequently manifests with orbital pain and diplopia. The diagnosis of ocular myositis falls within the overall classification of idiopathic orbital inflammatory diseases, defined as non-infective non-specific orbital inflammation without identifiable local or systemic causes. Orbital myositis may form part of more widespread systemic inflammatory processes such as Crohn's disease and the more recently described IgG4-related disease. There is also a broad range of ophthalmic differential diagnoses. Diagnosis, assessment and management of ocular myositis requires the cooperation of ophthalmologists and rheumatologists/immunologists in order to achieve the best patient outcomes. The current literature and avenues of future research are reviewed.

Entities:  

Mesh:

Year:  2013        PMID: 23093472     DOI: 10.1007/s11882-012-0319-7

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  57 in total

1.  Recurrent orbital myositis as an extra-intestinal manifestation of Crohn's disease.

Authors:  Rita Pimentel; Paula Lago; Isabel Pedroto
Journal:  J Crohns Colitis       Date:  2012-06-14       Impact factor: 9.071

2.  The efficacy of radiotherapy in the treatment of orbital pseudotumor.

Authors:  Chance Matthiesen; Carl Bogardus; J Spencer Thompson; Bradley Farris; Lloyd Hildebrand; Byron Wilkes; Elizabeth Syzek; Ozer Algan; Salahuddin Ahmad; Terence Herman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-29       Impact factor: 7.038

3.  Idiopathic orbital inflammation: a pathogenetic construct and treatment strategy: The 2005 ASOPRS Foundation Lecture.

Authors:  Gerald J Harris
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2006 Mar-Apr       Impact factor: 1.746

Review 4.  The evaluation and treatment of graves ophthalmopathy.

Authors:  Marius N Stan; James A Garrity; Rebecca S Bahn
Journal:  Med Clin North Am       Date:  2012-02-22       Impact factor: 5.456

5.  Intracranial extension and bone destruction in orbital pseudotumor.

Authors:  L P Frohman; M J Kupersmith; J Lang; D Reede; R T Bergeron; S Aleksic; S Trasi
Journal:  Arch Ophthalmol       Date:  1986-03

Review 6.  Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases.

Authors:  Lisa G Criscione; E William St Clair
Journal:  Curr Opin Rheumatol       Date:  2002-05       Impact factor: 5.006

7.  What has become of our idiopathic inflammatory pseudo-tumors of the orbit?

Authors:  T Maalouf; C Trouchaud-Michaud; K Angioi-Duprez; J L. George
Journal:  Orbit       Date:  1999-09

8.  Microbiology and antibiotic management of orbital cellulitis.

Authors:  L Barry Seltz; Jesse Smith; Vikram D Durairaj; Robert Enzenauer; James Todd
Journal:  Pediatrics       Date:  2011-02-14       Impact factor: 7.124

9.  Bilateral ocular myositis as a late complication of dermatomyositis.

Authors:  Panagiotis Kokotis; Panagiotis Theodossiadis; Christos Bouros; Petros P Sfikakis
Journal:  J Rheumatol       Date:  2005-02       Impact factor: 4.666

Review 10.  What is orbital pseudotumor?

Authors:  I Mombaerts; R Goldschmeding; R O Schlingemann; L Koornneef
Journal:  Surv Ophthalmol       Date:  1996 Jul-Aug       Impact factor: 6.048

View more
  9 in total

Review 1.  Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.

Authors:  Lisa G Rider; James D Katz; Olcay Y Jones
Journal:  Rheum Dis Clin North Am       Date:  2013-09-19       Impact factor: 2.670

2.  Painful ophthalmoplaegia secondary to orbital myositis.

Authors:  Jeremy Hoffman; Tessa Fayers
Journal:  BMJ Case Rep       Date:  2015-05-06

Review 3.  "Orbiting around" the orbital myositis: clinical features, differential diagnosis and therapy.

Authors:  F Montagnese; S Wenninger; B Schoser
Journal:  J Neurol       Date:  2015-10-17       Impact factor: 4.849

4.  [Ocular myositis as a rare cause of vision loss].

Authors:  J D Rollnik; H Requadt
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

Review 5.  Diagnosis, pathogenesis and treatment of myositis: recent advances.

Authors:  P-O Carstens; J Schmidt
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

6.  A rare case of ocular myositis.

Authors:  Carmen Valeria Albu; B Cătălin; Cornelia Zaharia
Journal:  Curr Health Sci J       Date:  2013-12-29

7.  Decreased CD3-CD16+CD56+ natural killer cell counts in children with orbital myositis: a clue to disease activity.

Authors:  Melissa R Briones; Gabrielle A Morgan; Maria C Amoruso; Bahram Rahmani; Maura E Ryan; Lauren M Pachman
Journal:  RMD Open       Date:  2017-07-11

Review 8.  Development of a core outcome set for amblyopia, strabismus and ocular motility disorders: a review to identify outcome measures.

Authors:  Samia Al Jabri; Jamie Kirkham; Fiona J Rowe
Journal:  BMC Ophthalmol       Date:  2019-02-08       Impact factor: 2.209

9.  Long-term Outcome in 7 Patients With Idiopathic Orbital Myositis.

Authors:  Toshihiko Matsuo
Journal:  Jpn Clin Med       Date:  2019-08-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.